BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29091824)

  • 1. Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Gspandl S; Peirson RP; Nahhas RW; Skale TG; Lehrer DS
    Psychiatry Res; 2018 Jan; 259():251-253. PubMed ID: 29091824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the self-rated 36-item World Health Organization Disability Assessment Schedule (WHODAS) 2.0 as a measure of functioning in Swedish psychiatric outpatients.
    Ramklint M; Söderberg P; Tungström S; Nordenskjöld A; Hermansson L
    Nord J Psychiatry; 2023 Apr; 77(3):276-281. PubMed ID: 35833609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the WHODAS 2.0 to Assess Functioning Among Veterans Seeking Compensation for Posttraumatic Stress Disorder.
    Marx BP; Wolf EJ; Cornette MM; Schnurr PP; Rosen MI; Friedman MJ; Keane TM; Speroff T
    Psychiatr Serv; 2015 Dec; 66(12):1312-7. PubMed ID: 26278226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Disability in Canadians with Mental Disorders Using an Abbreviated Version of a DSM-5 Emerging Measure: The 12-Item WHO Disability Assessment Schedule (WHODAS) 2.0.
    Sjonnesen K; Bulloch AG; Williams J; Lavorato D; B Patten S
    Can J Psychiatry; 2016 Apr; 61(4):227-35. PubMed ID: 27254415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing disability in older patients with schizophrenia: results from the WHODAS-II.
    McKibbin C; Patterson TL; Jeste DV
    J Nerv Ment Dis; 2004 Jun; 192(6):405-13. PubMed ID: 15167403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MIRECC version of the Global Assessment of Functioning scale: reliability and validity.
    Niv N; Cohen AN; Sullivan G; Young AS
    Psychiatr Serv; 2007 Apr; 58(4):529-35. PubMed ID: 17412856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and Reliability of the Japanese Version of the 12-item Self-administered World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in Patients with Schizophrenia.
    Wada R; Fujiwara M; Yamada Y; Nakaya N; Fujimori M; So R; Kodama M; Higuchi Y; Kakeda K; Uchitomi Y; Yamada N; Inagaki M
    Acta Med Okayama; 2021 Jun; 75(3):315-322. PubMed ID: 34176935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validity of the 12-item WHODAS-2.0 in a naturalistic sample of outpatients with psychotic disorders.
    Holmberg C; Gremyr A; Torgerson J; Mehlig K
    BMC Psychiatry; 2021 Mar; 21(1):147. PubMed ID: 33691655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
    Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.
    Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M
    Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II.
    Chopra PK; Couper JW; Herrman H
    Aust N Z J Psychiatry; 2004 Sep; 38(9):753-9. PubMed ID: 15324341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the 36-item and 12-item self-report World Health Organization Disability Assessment Schedule II (WHODAS-II) in individuals with autism spectrum disorder.
    Park SH; Demetriou EA; Pepper KL; Song YJC; Thomas EE; Hickie IB; Glozier N; Guastella AJ
    Autism Res; 2019 Jul; 12(7):1101-1111. PubMed ID: 31033250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSM-5 and the assessment of functioning: the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0).
    Gold LH
    J Am Acad Psychiatry Law; 2014; 42(2):173-81. PubMed ID: 24986344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Lo Cascio N; Curto M; Pasqualetti P; Lindau JF; Girardi N; Saba R; Brandizzi M; Monducci E; Masillo A; Colafrancesco G; Solfanelli A; De Crescenzo F; Kotzalidis GD; Dario C; Ferrara M; Vicari S; Girardi P; Auther AM; Cornblatt BA; Correll CU; Fiori Nastro P
    Psychiatry Res; 2017 Jul; 253():296-302. PubMed ID: 28412612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: towards evidence-guided rehabilitation intervention.
    Adegbaju DA; Olagunju AT; Uwakwe R
    Soc Psychiatry Psychiatr Epidemiol; 2013 Sep; 48(9):1405-15. PubMed ID: 23385802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
    Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.
    Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M
    J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.
    Guilera G; Gómez-Benito J; Pino O; Rojo JE; Cuesta MJ; Martínez-Arán A; Safont G; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Franco M; Rejas J
    Schizophr Res; 2012 Jul; 138(2-3):240-7. PubMed ID: 22521724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Employment Outcome for the People with Schizophrenia Using the WHODAS 2.0.
    Lu SJ; Liou TH; Yen CF; Chang FH; Chen YL; Escorpizo R; Strauser DR; Pan AW
    J Occup Rehabil; 2019 Jun; 29(2):375-383. PubMed ID: 29951935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.